Asia Pacific Dermal Fillers Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Biodegradable and Nonbiodegradable), Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polmethylmethacrylate (PMMA), Fat Fillers, and Others), Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment, and Others), and End User (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, and Others)

No. of Pages: 93
Report Code: TIPRE00025324
Category: Life Sciences
Asia Pacific Dermal Fillers Market
Buy Now

The Asia Pacific dermal fillers market was valued at US$ 854.98 million in 2023 and is expected to reach US$ 1,757.83 million by 2031; it is estimated to register a CAGR of 9.4% from 2023 to 2031.

Increasing Disposable Incomes and Expanding Middle-Class Population Drive Asia Pacific Dermal Fillers Market

 

As per the European Union, the middle-class population category will have more than 5.3 billion people globally by 2030. Most of this growth is likely to persist in Asia. By 2030, China and India are expected to represent approximately 65% of the global middle-class population. The expanding middle class is expected to boost economic development as well as change consumer behavior and consumption patterns. With more disposable income, changes in technology, and better after-care, the attitude toward cosmetic and skin-related conditions has changed, and the adoption of treatment procedures and home-based medical devices has increased. Furthermore, multinational corporations in the beauty and skincare industry explicitly target the massive Indian population and growing middle-class individuals due to the positive response received for their products. Thus, the increase in disposable income will likely fuel the adoption rate of beauty devices, providing lucrative opportunities for market growth.

 

Asia Pacific Dermal Fillers Market Overview

 

The Asia Pacific dermal fillers market is expected to grow at a high CAGR from 2023 to 2031. The market in China and Japan is expected to grow at a fast pace due to the increasing popularity of dermal fillers and growing medical tourism. In China, dermal fillers are gaining significant traction in various public and private hospitals. It is further increased due to higher disposable income and concerns related to looks. Moreover, India is emerging as one of the growing markets for dermal fillers owing to the aging population, increasing income, and affordability.

 

Asia Pacific Dermal Fillers Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Dermal Fillers Market Revenue and Forecast to 2031 (US$ Million)

 Asia Pacific Dermal Fillers Market Segmentation

 

The Asia Pacific Dermal Fillers Market is categorized into product, material, application, end user, and country.

 

Based on product, the Asia Pacific Dermal Fillers Market is bifurcated biodegradable and nonbiodegradable. The biodegradable segment held a larger market share in 2023.

 

In terms of material, the Asia Pacific Dermal Fillers Market is categorized calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polmethylmethacrylate (PMMA), fat fillers, and others. The hyaluronic acid segment held the largest market share in 2023.

 

By application, the Asia Pacific Dermal Fillers Market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. The lip enhancement segment held the largest market share in 2023.

 

By end user, the Asia Pacific Dermal Fillers Market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. The dermatology clinics segment held the largest market share in 2023.

 

By country, the Asia Pacific Dermal Fillers Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific Dermal Fillers Market share in 2023.

 

AbbVie Inc; BIOPLUS CO., LTD.; BIOXIS pharmaceuticals; Galderma SA; Merz Pharma GmbH & Co KGaA; Prollenium Medical Technologies; Sinclair Pharma Ltd; Suneva Medical; and TEOXANE LABORATORIES are some of the leading companies operating in the Asia Pacific Dermal Fillers Market.   

Asia Pacific Dermal Fillers Market Strategic Insights

global-market-strategic-framework
Get more information on this report

Asia Pacific Dermal Fillers Market Segmentation Analysis

Asia Pacific Dermal Fillers Market Report Highlights

Asia Pacific Dermal Fillers Report Scope

Report Attribute Details
Market size in 2023 US$ 854.98 Million
Market Size by 2031 US$ 1,757.83 Million
CAGR (2023 - 2031) 9.4%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Biodegradable
  • Nonbiodegradable
By Material
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Collagen
  • Poly-L-Lactic Acid
  • Polmethylmethacrylate
  • Fat Fillers
By Application
  • Facial Line Correction Treatment
  • Lip Enhancement
  • Face Lift
  • Scar Treatment
By End User
  • Multispecialty Hospitals
  • Dermatology Clinics
  • Ambulatory Surgical Centers
  • Others
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • AbbVie Inc
  • BIOPLUS CO., LTD.
  • BIOXIS pharmaceuticals
  • Galderma SA
  • Merz Pharma GmbH & Co KGaA
  • Prollenium Medical Technologies
  • Sinclair Pharma Ltd
  • Suneva Medical
  • TEOXANE LABORATORIES
Get more information on this report

Asia Pacific Dermal Fillers Market Country and Regional Insights

asia-pacific-dermal-fillers-market
Get more information on this report

The List of Companies - Asia Pacific Dermal Fillers Market

  1. AbbVie Inc                                        
  2. BIOPLUS CO., LTD.                                
  3. BIOXIS pharmaceuticals              
  4. Galderma SA                                  
  5. Merz Pharma GmbH & Co KGaA       
  6. Prollenium Medical Technologies             
  7. Sinclair Pharma Ltd                                        
  8. Suneva Medical                                         
  9. TEOXANE LABORATORIES                
Frequently Asked Questions
How big is the Asia Pacific Dermal Fillers Market?

The Asia Pacific Dermal Fillers Market is valued at US$ 854.98 Million in 2023, it is projected to reach US$ 1,757.83 Million by 2031.

What is the CAGR for Asia Pacific Dermal Fillers Market by (2023 - 2031)?

As per our report Asia Pacific Dermal Fillers Market, the market size is valued at US$ 854.98 Million in 2023, projecting it to reach US$ 1,757.83 Million by 2031. This translates to a CAGR of approximately 9.4% during the forecast period.

What segments are covered in this report?

The Asia Pacific Dermal Fillers Market report typically cover these key segments-

  • Product (Biodegradable, Nonbiodegradable)
  • Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polmethylmethacrylate,Fat Fillers)
  • Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment)
  • End User (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Others)

What is the historic period, base year, and forecast period taken for Asia Pacific Dermal Fillers Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Dermal Fillers Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in Asia Pacific Dermal Fillers Market?

    The Asia Pacific Dermal Fillers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AbbVie Inc
  • BIOPLUS CO., LTD.
  • BIOXIS pharmaceuticals
  • Galderma SA
  • Merz Pharma GmbH & Co KGaA
  • Prollenium Medical Technologies
  • Sinclair Pharma Ltd
  • Suneva Medical
  • TEOXANE LABORATORIES
  • Who should buy this report?

    The Asia Pacific Dermal Fillers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Dermal Fillers Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)